Диссертация (1174334), страница 32
Текст из файла (страница 32)
Carnahan, J. Fedor, A.Ashok, S. Gupta // Expert Rev of Obstet Gynecol. – 2013. - №8(1). – Р.2955.92. Cea Soriano, L. Incidence, treatment and recurrence of endometriosis in aUK-based population analysis using data from The Health ImprovementNetwork and the Hospital Episode Statistics database / L. Cea Soriano, E.López-Garcia, R. Schulze-Rath, L.A.
Garcia Rodríguez // Eur J ContraceptReprod Health Care. – 2017. - №22 (5). – Р.334-343.93. Cecchino, G.N. Endometrioma, fertility, and assisted reproductive treatments:connecting the dots / G.N. Cecchino, J.A. García-Velasco // Curr Opin ObstetGynecol. – 2018. – Р.29.94. Chandra, A. Clinical experience of long-term use of dienogest after surgeryfor ovarian endometrioma / A. Chandra, A. Rho, K. Jeong // Obstet GynecolSci. – 2018. - №61 (1). – Р.111-117. doi: 10.5468/ogs.2018.61.1.111.18895. Chon, S.J. Preoperative risk factors in recurrent endometrioma after primaryconservative surgery / S.J.
Chon, S.H. Lee, J.H. Choi, J.S. Lee // ObstetGynecol Sci. – 2016. - №59 (4). – Р.286-94.96. Chun, S. Comparison of early postoperative decline of serum antiMüllerianhormone levels after unilateral laparoscopic ovarian cystectomy betweenpatients categorized according to histologic diagnosis / S.
Chun, H.J. Cho,Y.I. Ji // Taiwan J Obstet Gynecol. – 2016. – №55 (5). – P.641-645. doi:10.1016/j.tjog.2015.06.016.97. Coccia, M.E. The effect of the hormonal milieu of pregnancy on deepinfiltrating endometriosis: serial ultrasound assessment of changes in size andpattern of deep endometriotic lesions / M.E. Coccia, F. Rizello // Eur J ObstetGynecolReprodBiol.2012.-№160(1).–Р.35-9.doi:10.1016/j.ejogrb.2011.10.00498. Coccia, M.E.
Bilateral Endometrioma Excision: Surgery-Related Damageto Ovarian Reservе / M.E. Coccia, F. Rizzello, T. Capezzuoli, P. Evangelisti,C. Cozzi, F. Petraglia // Reprod Sci. - 2018 Jan 1:1933719118777640.99. Coelho Neto, M.A. Counting ovarian antral follicles by ultrasound: a practicalguide / M.A. Coelho Neto, A. Ludwin, A. Borrell // Ultrasound ObstetGynecol. – 2018. - №51 (1).
- 10-20. doi: 10.1002/uog.100. Cristescu, C. Endometriosis - clinical approach based on histological findings/ C. Cristescu, A. Velişcu, B. Marinescu //Rom J Morphol Embryol. – 2013. –№54(1). – Р. 91-7.101. Da Broi, M. G. Oxidative stress and oocyte quality: ethiopathogenicmechanisms of minimal/mild endometriosis-related infertility / M. G. DaBroi, P.A. Navarro // Cell and Tissue Research. – 2016.
- Vol. 364. - № 1. –Р. 1–7.102. Deckers, P. Systematic review and meta-analysis of the effect of bipolarelectrocoagulationduringlaparoscopic ovarian endometriomastrippingon ovarian reserve / P. Deckers, S.C. Ribeiro, R.D.S. Simões, C. Miyahara,E.C. Baracat // Int J Gynaecol Obstet. – 2018. - №140(1). Р.
11-17.189103. Dewailly, D. The physiology and clinical utility of anti-Mullerian hormone inwomen / D. Dewailly // Hum Reprod Update. – 2014. - №20(3. - Р:370–385.104. Di Emidio, G. Increased levels of oxidative and carbonyl stress markers innormal ovarian cortex surrounding endometriotic cysts / G. Di Emidio, A.D'Alfonso, P. Leocata // Gynecol Endocrinol. – 2014. - №30(11).
– Р. 808-12.doi: 10.3109/09513590.2014.938625.105. Di Tucci, M.L., di Feliciantonio M., Galati G., Verrelli L., di Donato V.Management of Endometriomas / M.L. Di Tucci, M. di Feliciantonio, G.Galati, L. Verrelli, V. di Donato // Semin Reprod Med. – 2017. - №35. – Р.25-30.106. Dolleman, M. Reproductive and lifestyle determinants of anti-Mullerianhormone in a large population-based study / M. Dolleman, W.M. Verschuren, M.J. Eijkema ns, M.E. Dolle, E.H. Jansen, F.J. Broekmans, Y.T. vander Schouw // J Clin Endocrinol Metab. – 2013.
- №98. – Р.2106–2115.107. Donnez, J. Ovarian endometriosis and fertility preservation: a challenge in2018/ J. Donnez, J. García-Solares, M.M. Dolmans // Minerva Ginecol. –2018. -№70 (4). - Р.408-414. doi: 10.23736/S0026-4784.18.04229-6.108. Donnez J. Large ovarian endometriomas / J. Donnez, M. Nisolle, N. Gillet,M. Smets, S. Bassil // Hum Reprod. – 1996. - № 11.
– Р.641-646.109. Dumont A. Role of Anti-Müllerian Hormone in pathophysiology, diagnosisand treatment of Polycystic Ovary Syndrome: a review / A. Dumont, G.Robin, S. Jonard, D. Dewailly // Reprod Biol Endocrinol. – 2015. - №13 (1).– Р.137.110. Dunselman G.A. European Society of Human Reproduction and Embryology.ESHRE guideline: management of women with endometriosis / G.A.Dunselman, N. Vermeulen, C. Becker, C.
Calhaz-Jorge, T. D'Hooghe // HumReprod. - 2014. - № 29. – Р.400-412.111. Drăghici I.M.TheimmunoprofileofinterstitialCajalcellswithinadenomyosis/endometriosis lesions / I.M. Drăghici, L Drăghici // RomJ Morphol Embryol. - 2015. - №56 (1). – Р.133-8.190112. Errázuriz, V.J. Association between antral follicle count and age in fertilewomen / V.J.
Errázuriz, Á. Carrasco, R.E. Díaz, R.P. Sanhueza, S.P.González, P.P. Donoso // Rev Med Chil. – 2017. - №145 (6). – Р.741-746.113. Evans, M.B. Fertility and Endometriosis / M.B. Evans, A.H. Decherney //Clin Obstet Gynecol. 2017. - №60 (3). – Р.497-502.114. Exacoustos, C. Recurrence of endometriomas after laparoscopic removal:sonographic and clinical follow-up and indication for second surgery / C.Exacoustos, E. Zupi, A. Amadio, C.
Amoroso, B. Szabolcs, M.E. Romanini //J MinimInvasive Gynecol. – 2006. - №13. – Р.281–8.115. Exacoustos, C. Imaging for the evaluation of endometriosis and adenomyosis/ C. Exacoustos, L. Manganaro, E. Zupi // Best Pract Res Clin ObstetGynaecol. – 2014. - №28 (5). – Р.655-81.116. Fadia J Aizzi. Recurrent Endometrioma; Outcome of Medical Managementwith Dienogest / Fadia J Aizzi // European Journal of Experimental Biology. 2017.
- Vol.7 №.6:39. –P.1-5.117. Falcone, T. Clinical Management of Endometriosis / T. Falcone, R. Flyckt //Obstet Gynecol. – 2018. - №131 (3). – Р.557-571.118. Ferrero, S. Current and Emerging Therapeutics for the Managementof Endometriosis / S. Ferrero , F. Barra, U. Leone Roberti Maggiore // Drugs.– 2018. - №78 (10). - 995-1012.119. Ferrero, S. Second surgery for recurrent unilateral endometriomas and impacton ovarian reserve: a case-control study / S. Ferrero , C. Scala, A. Racca, L.Calanni, V. Remorgida, P.L. Venturini, U. Leone Roberti Maggiore // FertilSteril. – 2015. - №103(5). – Р.1236-43.120.
Freeman E.W. Anti-mullerian hormone as a predictor of time to menopause inlate reproductive age women / E.W. Freeman, M.D. Sammel, H.Lin., C.R.Gracia // J Clin Endocrinol Metab . – 2012. - №97 (5). – Р. 1673-80. doi:10.1210/jc.2011-3032.121. Garavaglia, E. Fertility Preservation in Endometriosis Patients: AntiMüllerian Hormone Is a Reliable Marker of the Ovarian Follicle Density / E.191Garavaglia, C. Sala, G. Taccagni, M. Traglia, C. Barbieri, S.
Ferrari // FrontSurg. – 2017. - № 25. Р.4 -40.122. Garcia-Velasco, J.A. Management of endometriomas in women requiringIVF: to touch or not to touch / J.A. Garcia-Velasco, E. Somigliana // HumReprod. – 2009. - № 24. – Р.496-501.123. Ghezzi, F. Recurrence of ovarian endometriosis and anatomical location ofthe primary lesion / F. Ghezzi, P. Beretta, M. Franchi, M. Parissis, P. Bolis //Fertil Steril. – 2001. – №.75. – Р.136-40.124. Giudice, L.C. Endometriosis / L.C. Giudice, L.
Kao // The Lancet. – 2006. №364. – Р.1789-1799.125. Gracia, C.R. Multi-center clinical evaluation of the Access AMH assay todetermine AMH levels in reproductive age women during normal menstrualcycles / C.R. Gracia, S.S. Shin, M. Prewitt // J Assist Reprod Genet. – 2018. №35 (5). – Р.777-783. doi: 10.1007/s10815-018-1141-5.126. Guerriero, S. Age-related differences in the sonographic characteristics ofendometriomas / S.
Guerriero , B. Van Calster, E. Somigliana, S. Ajossa //Hum Reprod. - 2016. - №31 (8). – Р.1723-31.127. Guler I. The Impact of laparoscopic surgery of peritoneal endometriosis andendometrioma on the outcome of ICSI cycles / I. Guler, A. Erdem, Y. Oguz,F. Cevher, M.F. Mutlu, N. Bozkurt, M. Oktem, M. Erdem // Syst Biol ReprodMed. – 2017. - №63(5). – Р.324-330.128. Guo S.W. Recurrence of endometriosis and its control / S.W. Guo // HumReprod Update.
– 2009. - №15. – Р.441–61.129. Hadlow N. Variation in antimullerian hormone concentration during themenstrual cycle may change the clinical classification of the ovarian response/ N. Hadlow, K. Longhurst, A. McClements, J. Natalwala, S.J. Brown,P.L.Matson // Fertil Steril. – 2013. – №99. – Р.1791–1797.130. HanA.R.Riskfactorsandbiomarkersfortherecurrenceofovarian endometrioma: about the immunoreactivity of progesterone receptor192isoform B and nuclear factor kappa B / A.R.
Han, T.H. Lee, S. Kim, H.Y. Lee// Gynecol Endocrinol. – 2017. - №33 (1). – Р.70-74.131. Hansen K.R. A new model of reproductive aging: the decline in ovarian nongrowing follicle number from birth to menopause / K.R. Hansen, N.S.Knowlton, A.C. Thyer, J.S. Charleston, M.R. Soules, N.A. Klein // HumReprod. – 2008. - № 23. – Р.699–708.132. Harlev A. Targeting oxidative stress to treat endometriosis / A. Harlev, S.Gupta, A. Agarwal // Expert Opinion on Therapeutic Targets. – 2015. - Vol.19. - №11.
– P.1447–1464.133. Henes M. Ovarian cyst removal influences ovarian reserve dependent onhistology, size and type of operation / M. Henes, T. Engler, F.A.Taran, S.Brucker, K. Rall, B.Janz, Lawrenz B. // Womens Health (Lond). - 2018 JanDec.134. He X.-H. Non-Hormonal Targets Underlying Endometriosis: A Focus onMolecular Mechanisms / X.-H. He // Molecular Reproduction &Development. - 2015. - №82. – P.410–431.135.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
